Kenvue Inc. Files 8-K: Material Agreement & Exhibits

Ticker: KVUE · Form: 8-K · Filed: 2025-05-21T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, filing-update, exhibits

Related Tickers: KVUE

TL;DR

Kenvue signed a big deal, filing it with the SEC today.

AI Summary

On May 20, 2025, Kenvue Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibits. Kenvue Inc., incorporated in Delaware, has its principal executive offices in Summit, New Jersey.

Why It Matters

This filing indicates Kenvue Inc. has entered into a significant agreement, which could impact its business operations and financial standing.

Risk Assessment

Risk Level: low — The filing is a standard disclosure of a material agreement and does not inherently present new risks.

Key Numbers

Key Players & Entities

FAQ

What type of material definitive agreement did Kenvue Inc. enter into?

The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on or before May 20, 2025.

What is the significance of filing financial statements and exhibits with this 8-K?

The inclusion of financial statements and exhibits suggests these are relevant to the material definitive agreement or other significant corporate events being reported.

When was Kenvue Inc. incorporated?

Kenvue Inc. was incorporated in Delaware.

What is Kenvue Inc.'s principal executive office address?

Kenvue Inc.'s principal executive offices are located at 1 Kenvue Way, Summit, New Jersey 07901.

What is the accession number for this filing?

The accession number for this filing is 0001628280-25-026974.

From the Filing

0001628280-25-026974.txt : 20250521 0001628280-25-026974.hdr.sgml : 20250521 20250521060031 ACCESSION NUMBER: 0001628280-25-026974 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250520 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250521 DATE AS OF CHANGE: 20250521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kenvue Inc. CENTRAL INDEX KEY: 0001944048 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 03 Life Sciences EIN: 881032011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41697 FILM NUMBER: 25970790 BUSINESS ADDRESS: STREET 1: 1 KENVUE WAY CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 908-874-1200 MAIL ADDRESS: STREET 1: 1 KENVUE WAY CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER COMPANY: FORMER CONFORMED NAME: JNTL, Inc. DATE OF NAME CHANGE: 20220825 8-K 1 kvue-20250520.htm 8-K kvue-20250520 0001944048 False 0001944048 2025-05-20 2025-05-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 20, 2025 Kenvue Inc. (Exact name of registrant as specified in its charter) Delaware 001-41697 88-1032011 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 1 Kenvue Way Summit , New Jersey 07901 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 908 )- 874-1200 Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share KVUE New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement On May 20, 2025, Kenvue Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc. and Deutsche Bank Securities Inc., as Representatives for the several Underwriters (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $750,000,000 aggregate principal amount of the Company’s 4.850% Senior Notes due 2032 in an underwritten public offering (the “Offering”) pursuant to the Company’s registration statement on Form S-3 (Registration File No. 333-285172). The Company intends to use the net proceeds from the Offering for general corporate purposes. The foregoing description of the Underwriting Agreement does not purport to

View on Read The Filing